文献速递慢性肾脏病

不同算法定义的4期慢性肾脏病发病率与预后差异:基于人群的队列研究

Variations in Incidence and Prognosis of Stage 4 CKD Among Adults Identified Using Different Algorithms: A Population-Based Cohort Study.
PubMed 文献 · Am J Kidney Dis · 2023-12-10

该研究在加拿大阿尔伯塔省基于行政与实验室数据,比较四种门诊eGFR算法定义的CKD G4队列的发病率和1年预后。结果显示算法越严格,发病率越低(从190.7降至79.9/10万人年),且识别出的队列eGFR改善概率更低、肾衰竭风险更高。

要点

  • 不同算法定义的CKD G4发病率差异显著,严格算法下发病率更低。
  • 基于持续eGFR降低的算法识别的患者eGFR改善概率更低、肾衰竭风险更高。
  • 临床报告和研究中选择的CKD定义算法会影响疾病负担估计和个体预后判断。

核心结论

  • 使用更严格的CKD G4定义算法会显著降低发病率估计,并识别出eGFR改善概率更低、肾衰竭风险更高的群体。

研究设计与样本

  • 基于加拿大阿尔伯塔省人群的队列研究,纳入2015年4月1日至2018年3月31日期间新诊断的CKD G4(eGFR 15-29mL/min/1.73m2)成人居民。

主要发现

  • CKD G4发病率随算法严格程度增加而下降,从单次检测的190.7/10万人年降至严格持续算法的79.9/10万人年。
  • 基于持续eGFR降低的两个队列规模相当,1年事件特异性概率相似;单次检测和两次检测序列的两个队列规模更大,eGFR改善概率更高。

关键数值与推荐

  • 算法1:单次eGFR检测;算法2:首次eGFR<30mL/min/1.73m2且间隔>90天的第二次eGFR 15-29mL/min/1.73m2;算法3:≥2次eGFR<30mL/min/1.73m2持续>90天且合格期最后一次eGFR为15-29mL/min/1.73m2;算法4:≥2次连续eGFR 15-29mL/min/1.73m2持续>90天。

临床怎么用

  • 在临床报告系统和研究中选择CKD G4定义算法时需考虑其对发病率估计和预后分层的影响。
  • 更严格的算法可能有助于识别肾衰竭风险更高、eGFR改善可能性更低的患者,辅助转诊和治疗决策。

局限性

  • 随访时间仅1年,且人群以白人为主。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Clinical guidelines define chronic kidney disease (CKD) as abnormalities of kidney structure or function for>3 months. Assessment of the duration criterion may be implemented in different ways, potentially impacting estimates of disease incidence or prevalence in the population, individual diagnosis, and treatment decisions, especially for more severe cases. We investigated differences in incidence and prognosis of CKD stage G4 identified by 1 of 4 algorithms. STUDY DESIGN: Population-based cohort study in Alberta, Canada. SETTING & PARTICIPANTS: Residents>18 years old with incident CKD stage G4 (eGFR 15-29mL/min/1.73m2) diagnosed between April 1, 2015, and March 31, 2018, based on administrative and laboratory data. EXPOSURE: Four outpatient eGFR-based algorithms, increasing in stringency, for defining cohorts with CKD G4 were evaluated: (1) a single test, (2) first eGFR<30mL/min/1.73m2 and a second eGFR 15-29mL/min/1.73m2 measured>90 days apart (2 tests), (3) ≥2 eGFR measurements of<30mL/min/1.73m2 sustained for>90 days (qualifying period) and the last eGFR in the qualifying period of 15-29mL/min/1.73m2 (relaxed sustained), and (4) ≥2 consecutive measurements of 15-29mL/min/1.73m2 for>90 days (rigorous sustained). OUTCOME: Time to the earliest of death, eGFR improvement (a sustained increase in eGFR to≥30mL/min/1.73m2 for>90 days and>25% increase from the index eGFR), or kidney failure. ANALYTICAL APPROACH: For each of the 4 cohorts, incidence rates and event-specific cumulative incidence functions at 1 year from cohort entry were estimated. RESULTS: The incidence rates of CKD G4 decreased as algorithms became more stringent, from 190.7 (single test) to 79.9 (rigorous sustained) per 100,000 person-years. The 2 cohorts based on sustained reductions in eGFR were of comparable size and 1-year event-specific probabilities. The 2 cohorts based on a single test and a 2-test sequence were larger and experienced higher probabilities of eGFR improvement. LIMITATIONS: A short follow-up period of 1 year and a predominantly White population. CONCLUSIONS: The use of more stringent algorithms for defining CKD G4 results in substantially lower estimates of disease incidence, the identification of a group with a lower probability of eGFR improvement, and a higher risk of kidney failure. These findings can inform implementation decisions of disease definitions in clinical reporting systems and research studies. PLAIN-LANGUAGE SUMMARY: Although guidelines recommend>3 months to define chronic kidney disease (CKD), the methods for defining specific stages, particularly G4 (eGFR 15-29mL/min/1.73m2) when referral to nephrology services is recommended, have been implemented differently across studies and surveillance programs. We studied differences in incidence and prognosis of CKD G4 cohorts identified by 4 algorithms using administrative and outpatient laboratory databases in Alberta, Canada. We found that, compared with a single-test definition, more stringent definitions resulted in a lower disease incidence and identified a group with worse short-term kidney outcomes. These findings highlight the impact of the choice of algorithm used to define CKD G4 on disease burden estimates at the population level, on individual prognosis, and on treatment/referral decisions.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Rath M, Ravani P, James MT, et al. Variations in Incidence and Prognosis of Stage 4 CKD Among Adults Identified Using Different Algorithms: A Population-Based Cohort Study. Am J Kidney Dis. 2023. PMID: 38072211. doi:10.1053/j.ajkd.2023.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。